Findings have possible implications for reproductive technologies

Researchers from the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin and the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna have uncovered a mechanism that may allow for a "pause button" in the earliest stages of human development. This discovery could have significant implications for our understanding of early human life and potential applications in reproductive technologies.

Unveiling a Dormant State in Human Cells

In certain mammals, embryonic development can be temporarily halted—a process known as embryonic diapause—to enhance the survival prospects of both the embryo and the mother. This pause typically occurs at the blastocyst stage, just before the embryo implants in the uterus, and can extend pregnancy for weeks or even months until conditions become favorable for continued development.

While embryonic diapause is well-documented in some species, it remained unclear whether human cells possess a similar capability. Research teams from MPIMG and IMBA investigated this possibility using human stem cells and stem cell-derived blastocyst models known as blastoids.

The Role of the mTOR Signaling Pathway

Using blastoids as an ethical and scientific alternative to human embryos, the scientists discovered that modulating the mechanistic target of rapamycin (mTOR) signaling pathway—a crucial regulator of cell growth and development—could induce a dormant state in these models. Treatment of human stem cells and blastoids with an mTOR inhibitor resulted in a developmental delay, suggesting that human cells can activate the molecular machinery to enter a diapause-like state.

During this induced dormancy, cells exhibited reduced division rates, slower development, and a decreased ability to attach to the uterine lining. Notably, this dormant state was reversible; once the mTOR pathway was reactivated, the blastoids resumed normal development. The capacity to enter dormancy appeared limited to a specific window in early development, aligning with the blastocyst stage where diapause occurs in other mammals.

Implications for Reproductive Medicine

The findings suggest that humans may retain an inherent mechanism to temporarily slow down embryonic development, even if it is not naturally utilized during pregnancy. Although this mechanism might be an evolutionary vestige that is no longer employed, the experiments indicate that this capability exists at a cellular level and could potentially be harnessed.

Controlling the timing of embryonic development holds promising implications for reproductive technologies such as in vitro fertilization (IVF). Enhancing mTOR activity could accelerate development, which is known to improve IVF success rates. Conversely, inducing a dormant state during IVF could provide a larger window to assess embryo health and better synchronize implantation with the mother's uterine environment.

A Collaborative Effort Advancing Science

The study highlights the power of collaborative research in tackling complex biological questions. By bringing together diverse expertise, the researchers advanced the understanding of fundamental processes governing early human development. Their work opens up new avenues for exploring how cells interpret various signals as they embark on their developmental journey.

Future Directions

The researchers aim to further investigate whether human and other mammalian cells utilize similar or distinct pathways to enter dormancy and how this mechanism can be applied for clinical benefits. Understanding the intricacies of this "pause button" could lead to innovations in reproductive health and provide deeper insights into the earliest stages of human life.

Sources

• Original study published on September 26, 2024, in the journal Cell: Link to the article
• Press release from Max Planck Institute for Molecular Genetics
• Article in Genetic Engineering & Biotechnology News: IVF Could Be Improved if Disused “Pause Button” in Embryos Is Pressed